Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideki Kudo is active.

Publication


Featured researches published by Hideki Kudo.


American Journal of Obstetrics and Gynecology | 1983

Effects of estrogen and progesterone on thymidine kinase activity in the immature rat uterus

Shinobu Sakamoto; Akio Abe; Hideki Kudo; Noriko Yamada; Keiko Seki; Ryohei Okamoto

The effects of progesterone and/or 17 beta-estradiol on thymidine kinase activity and autoradiograms were investigated in immature rats. Thymidine kinase activity increased more than thirtyfold above the control level 30 hours after 17 beta-estradiol injection. The enzyme activity induced by 17 beta-estradiol was suppressed by progesterone, the dose of which was approximately 1,000-fold that of 17 beta-estradiol. The specific thymidine kinase isozyme, which was separated from 17 beta-estradiol-induced uterine thymidine kinase by diethylaminoethyl (DEAE) cellulose column chromatography and not affected by deoxycytidine triphosphate, was involved in the DNA replication and inhibited by progesterone. The autoradiogram revealed many grains due to 3H-thymidine in the endometrial epithelium, stroma, and the myometrium in the immature rat 30 hours after 17 beta-estradiol injection, whereas progesterone reduced remarkably the number of grains induced by 17 beta-estradiol in the epithelium. Progesterone seems to inhibit the increment of the specific thymidine kinase isozyme induced by 17 beta-estradiol in the endometrial epithelium.


The American Journal of Chinese Medicine | 1991

Anticancer effects of a chinese Herbal medicine, Juzen-taiho-to, in combination with or without 5-fluorouracil derivative on DNA-synthesizing enzymes in 1,2-dimethylhydrazine induced colonic cancer in rats

Shinobu Sakamoto; Hideki Kudo; Kuwa K; Satoe Suzuki; Tomoyasu Kato; Tohru Kawasaki; Tohru Nakayama; Noriyuki Kasahara; Ryohei Okamoto

Juzen-taiho-to (JTT; [Shi-quan-da-bu-tang], a Japanese modified Chinese herbal prescription) in combination with an anticancer drug UFT (5-fluorouracil derivative) prevented the body weight loss and the induction of the colonic cancer in rats treated with a chemical carcinogen 1,2-dimethylhydrazine (DMH), and suppressed markedly the activity of thymidylate synthetase (TS) involved in the de novo pathway of pyrimidine synthesis in colonic cancer induced by DMH.


Fertility and Sterility | 2003

Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice

Ying-Fang Zhou; Takao Mori; Hideki Kudo; Rei Asakai; Shuji Sassa; Shinobu Sakamoto

OBJECTIVE To investigate the effects of angiogenesis inhibitor TNP-470 on uterine microvessels in mice. Pituitary grafting frequently induced uterine adenomyosis. DESIGN In vivo experimental study. SETTING Department of Biological Sciences, University of Tokyo and Medical Research Institute, Tokyo Medical and Dental University. ANIMAL(S) SHN mice, which are known to develop uterine adenomyosis spontaneously, and also very soon after pituitary grafting. INTERVENTION(S) Immunohistochemical study on uterine blood vessels using an antibody to von Willebrand factor in pituitary gland-implanted mice with or without TNP-470. MAIN OUTCOME MEASURE(S) Reduced incidence of uterine adenomyosis. RESULT(S) Twelve of 15 mice developed uterine adenomyosis with dilated blood vessels, but none of the TNP-470-treated mice with shrunken microvessels. The number of bromodeoxyuridine immunoreactive cells and activities of thymidylate synthase and thymidine kinase in uterine tissues were markedly reduced in TNP-470-treated mice. CONCLUSION(S) TNP-470, a potent inhibitor of the development of vascular endothelium, reduced the development of endometrial blood vessels resulting in a lowered incidence of uterine adenomyosis induced by pituitary grafting in mice, and reduced the increase in S-phase cells and enzyme activity for pyrimidine nucleotide synthesis.


Life Sciences | 2001

Splenomegaly induced by recombinant human granulocyte-colony stimulating factor in rats

Tohru Nakayama; Hideki Kudo; Satoe Suzuki; Shuji Sassa; Yoshihiro Mano; Sakamoto S

Spontaneous ruptures of the spleen have been observed in donors and patients with malignancy during mobilization of peripheral blood stem cells. Thus, we investigated the morphological and histological alteration of the spleen, and mRNA expression levels and activities of the DNA-synthesizing enzymes thymidylate synthase (TS) and thymidine kinase (TK) in the splenic cells, of rats treated with recombinant human granulocyte-colony stimulating factor (rhG-CSF). Daily injections of rhG-CSF for 5 or 7 days slightly enhanced the splenic weight. Single or 3-day treatment with rhG-CSF markedly enhanced the number of granulocytes in peripheral blood. Expression levels of TS and TK mRNA in the splenic cells were significantly increased 6 hours after rhG-CSF treatment. Early expression of TS and TK mRNA in the splenic cells may indicate a reseeding of hematopoietic cells from the bone marrow. Daily injections with rhG-CSF enhanced the TS and TK activities in the splenic cells. As continuous elevations of DNA-synthesizing enzyme activity and spleno-megaly are suggestive of a possible splenic rupture, the monitoring of peripheral granulocytes and splenic size is necessary during the rhG-CSF treatment.


Cells Tissues Organs | 1992

Increase of DNA Synthesis in Uterine Adenomyosis in Mice with Ectopic Pituitary Isograft

Sakamoto S; Takao Mori; Tippawan Singtripop; Seiichiro Kawashima; Satoe Suzuki; Hideki Kudo; Sawaki K; Hiroshi Nagasawa

Ectopic pituitary isografts (EPI) have been found to induce a high incidence of uterine adenomyosis in SHN mice. All the SHN mice given EPI in the right uterus at 40 days of age developed uterine adenomyosis, and more than 80% of mice showed the genesis of subserosal nodules, an advanced state of adenomyosis, 65 days after EPI. Activities of both thymidylate synthetase and thymidine kinase, i.e. DNA-synthesizing enzymes in de novo and salvage pathways of pyrimidine metabolism, respectively, were significantly increased in EPI-induced uterine adenomyosis to approximately 2-fold those in normal control uteri. Bromodeoxyuridine-immunoreactive cells were regarded as the cells in S phase, and the number in the endometrial epithelium and stroma in EPI-induced uterine adenomyosis was more than 1.5-fold that in normal control uteri. EPI may affect the genesis of uterine adenomyosis generally, but not locally, because there were no differences between the right uterus with EPI and the left without EPI in the incidence of adenomyosis, histology or DNA-synthesizing enzyme activities.


Anti-Cancer Drugs | 2007

Chemopreventive effect of a vitamin D3 analog, alfacalcidol, on colorectal carcinogenesis in mice with ulcerative colitis

Hiroyuki Kikuchi; Saburou Murakami; Satoe Suzuki; Hideki Kudo; Shuji Sassa; Shinobu Sakamoto

An increased incidence of colorectal carcinoma is known to occur in patients with ulcerative colitis (UC), which displays a cycle of recurrence–remission in the colorectal mucosa. Repeated oral doses of 3% dextran sulfate sodium subsequent to a single intraperitoneal injection of azoxymethane induced a chronic UC resulting in an increased incidence of high-grade dysplasia and submucosal-invasive adenocarcinomas in the mouse colorectum. The active form of vitamin D3 is a calcium-regulating hormone that increases serum calcium levels and intestinal calcium absorption. It has been reported that there is an inverse correlation between serum levels of the active metabolite of vitamin D and colorectal carcinoma stage. The features of the colitis induced in this animal model are very similar to the UC in patients in terms of both clinical and histological characteristics. Treatment with a vitamin D3 analog, alfacalcidol, in mice prevented colitis and carcinogenesis; this is shown by inhibition of the decrease in colorectal length and inhibition of the increased incidence of colorectal dysplasia, with a reduction in the mRNA expression of the DNA-synthesizing enzyme, thymidine kinase, in colorectal tissues.


Nutrition & Metabolism | 2008

Down regulation by a low-zinc diet in gene expression of rat prostatic thymidylate synthase and thymidine kinase

Yuko Ishikawa; Hideki Kudo; Satoe Suzuki; Nahoko Nemoto; Shuji Sassa; Shinobu Sakamoto

BackgroundZinc has a wide spectrum of biological activities and its deficiency is related to various abnormalities of cell metabolism.MethodsWistar male rats, at age of 4 weeks, were fed a low-zinc diet for six weeks. The levels of bromodeoxyuridine incorporated into the prostatic DNA and the mRNA expression levels of prostate thymidylate synthase and thymidine kinase were examined.ResultThe low-zinc diet caused a marked reduction in the body growth and organ weights, resulted in a low hematopoiesis, hypo-albuminemia and hypocholesterolemia. Although there were few differences in plasma biochemical markers, plasma levels of luteinizing hormone and testosterone were reduced by the low-zinc diet. Bromodeoxyuridine-immunoreactive (S-phase) cells and mRNA expression levels of thymidylate synthase and thymidine kinase in the prostate cells were markedly affected by the low-zinc diet.ConclusionA low-zinc diet appears to reduce the body growth and organ weights including prostate, causing low plasma levels of luteinizing hormone and testosterone and reduction in prostate DNA replication in growing-rats.


Toxicology Letters | 1984

Effects of estrogen and prolactin on thymidine kinase isozyme activities in DMBA-induced rat mammary tumor.

Shinobu Sakamoto; Tohru Kawasaki; Haruo Yoshino; Hideki Kudo; Ryohei Okamoto

Effects of prolactin or estrogen on the activity of the pyrimidine salvage pathway enzyme thymidine kinase (TK) in 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary tumors were investigated in ovariectomized rats. Prolactin induced by perphenazine administration significantly enhanced the activities of total TK or its isozyme in the tumors. This specific TK isozyme separated by DEAE-cellulose column chromatography was suggested to be involved in DNA synthesis because it was not affected by dCTP. Its Mr was estimated to be approx. 100 000 by high-performance liquid chromatography. In contrast, estrogen alone did not raise the activity of the specific TK isozyme in the tumors.


Cell Biology International | 2002

EARLY PROGRESSION FROM DIMETHYL SULFOXIDE-INDUCED G0/G1 ARREST IN L1210 CELLS

Hideki Kudo; Tohru Nakayama; Yoshihiro Mano; Satoe Suzuki; Shuji Sassa; Shinobu Sakamoto

Recently, dimethyl sulfoxide (DMSO) has been used as a convenient cryoprotectant for stem cells in stem cell transplantation using allogenic peripheral blood or umbilical cord blood. As the stem cells have a multipotency, clarification of the extent of cell proliferation after transplantation is difficult. In the present study, DMSO gradually induced G0/G1 arrest in mouse leukemia L1210 cells with good cell viability. After removal of DMSO, the cells proliferated appropriately, resulting in expression of the DNA‐synthesizing enzymes thymidylate synthase and thymidine kinase within 6h, and the cells entering into S phase within 12h. The sequence was followed by the marked activation of both enzymes within 24h and the increase of bromodeoxyuridine (BrdU) immunoreactive (S phase) cells with rapid cell proliferation within 36h. In conclusion, mouse leukemia L1210 cells, which were treated with 1.5% DMSO for 96h, tolerated the treatment and reversed the cell cycle arrest within 36h.


Calcified Tissue International | 1999

Prevention of Osteopenia Induced with a Gonadotropin-Releasing Hormone Agonist in Rats

Sakamoto S; Shuji Sassa; Tadasu Mitamura; Hideki Kudo; Satoe Suzuki; Shintarou Yoshimura; Y.-F. Zhou; Takashi Kikuchi; Hisashi Shinoda

Abstract. We investigated the effects of conjugated estrogens as an add-back replacement drug, incadronate sodium as a bisphosphonate, and alfacalcidol as a vitamin D3 analog on femoral bone mineral density (BMD) and bone mineral content (BMC) in female rats chronically treated with the gonadotropin-releasing hormone (GnRH) agonist leuprorelin acetate. The chemical castration of the rats by the administration of GnRH agonist for 16 weeks reduced the BMD values to 92.3%, 91.3%, and 93.3% of those of the normal control animals in the whole femur, metaphysis, and diaphysis of the femur, respectively. The BMC value was decreased to 91.0% of that of the normal control animals by the chronic GnRH agonist treatment. However, a simultaneous 8-week administration of conjugated estrogens, bisphosphonate, and vitamin D3 analog markedly augmented the BMC values to 110.3%, 110.1%, and 114.4%, respectively, of those in the rats treated with the GnRH agonist alone. These findings indicate that antiosteoporotic agents could be useful for preventing induced osteopenia under the careful monitoring of biochemical markers of osteoblastic activity or bone resorption and BMD or BMC in patients undergoing GnRH treatment.

Collaboration


Dive into the Hideki Kudo's collaboration.

Top Co-Authors

Avatar

Satoe Suzuki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Shinobu Sakamoto

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Shuji Sassa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Sakamoto S

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kuwa K

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Noriyuki Kasahara

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Ryohei Okamoto

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tadasu Mitamura

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Tohru Nakayama

Tokyo Medical and Dental University

View shared research outputs
Researchain Logo
Decentralizing Knowledge